Overview

Study Comparing 2 New Formulations of HKI-272 in Healthy Adult Subjects

Status:
Completed

Trial end date:
2007-09-01

Target enrollment:

Participant gender:

Summary

To evaluate the comparative bioavailability of 2 new tablet formulations of HKI-272 with a reference capsule and an oral solution in healthy subjects.

Phase:

Phase 1

Details

Lead Sponsor:

Puma Biotechnology, Inc.